BML, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,809 JPY | -2.43% |
|
-5.26% | -6.30% |
| May. 14 | Boab Metals Completes AU$1.7 Million Placement, Opens AU$3.3 Million Entitlement Offer | MT |
| May. 07 | Auric Mining Processes 30,300 Metric Tonnes from Jeffreys Find Gold Mine; Shares Up 6% | MT |
ETFs positioned on BML, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 22 M€ | +3.60% | - | |
| 0.10% | 19 M€ | +6.59% | ||
| 0.02% | 70 M€ | +16.33% | ||
| 0.02% | 9,760 M€ | +17.04% | ||
| 0.02% | 4,929 M€ | +16.57% | ||
| 0.02% | 17 M€ | +11.76% | - | |
| 0.01% | 746 M€ | -.--% | - | |
| 0.01% | 140,441 M€ | +16.31% | ||
| 0.01% | 63,295 M€ | +16.38% | - | |
| 0.01% | 20,360 M€ | +15.24% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 34 M€ | +4.06% | - |
BML, INC. is mainly engaged in the clinical testing as well as related business. The Testing segment engages in the commissioned work of clinical testing. The Medical Information Systems segment is engaged in the manufacturing and sales of system equipment for medical institutions, as well as provision of medical information service.
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
2,879
JPY
Average target price
2,967
JPY
Spread / Average Target
+3.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.30% | 735M | |
| -15.96% | 8.79B | |
| +67.50% | 4.19B | |
| -4.03% | 2.48B | |
| -42.54% | 2.29B | |
| -6.49% | 1.97B | |
| -20.45% | 1.56B | |
| -41.24% | 1.22B | |
| +10.26% | 1.13B | |
| +18.74% | 933M |
- Stock Market
- Equities
- 4694 Stock
- Funds and ETFs BML, Inc.
